Illustration by Lincoln Brown

A Cambridge-based energy company that’s collaborating with Massachusetts Institute of Technology on climate change-fighting technology will occupy a new 160,000-square-foot manufacturing facility developed by King Street Properties of Boston at Devens.

Commonwealth Fusion Systems’ project is scheduled to break ground this spring on a 47-acre parcel owned by King Street Properties. CFS will locate its corporate offices and the manufacturing facility at the Devens site.

The company is collaborating with MIT on design and construction of a device that uses high-temperature magnets to generate power, with a demonstration project scheduled in June. CFS will manufacture the magnets at Devens.

“This will be the site where we harness fusion and prove it can work as a clean, limitless power source for the first time in history,” CFS CEO Bob Mumgaard said in a statement.

After developing R&D facilities for life science companies in Cambridge and the Boston suburbs, King Street Properties has branched out into Metrowest and the state-run Devens campus for development opportunities in biomanufacturing and other technology. The firm acquired 45 acres at Devens last summer from MassDevelopment, the state economic development and financing agency.

In November, King Street Properties broke ground on a 100,000-square-foot biomanufacturing facility at 45 Jackson Road at Devens, part of a planned five-building, 700,000-square-foot campus.

And a major existing Devens occupant, Bristol-Myers Squibb, announced last month that it has begun construction of a 244,000-square-foot cell therapy manufacturing facility on its 89-acre Devens campus.

“Historically we have had many technologies that change the world start in Massachusetts, and when Commonwealth Fusion Systems does it by bringing fusion energy technology to life we will be able to say they did it at their first-of-its-kind campus in Devens,” MassDevelopment CEO Dan Rivera said in a statement.